Repeated Low-level Red Light for Myopia Progression Study: An International, Multicenter, Multiethnic, Randomized Controlled Trial, IPOSC Study

Summary

The purpose of this clinical trial is to see if and how well Repeated Low-Level Red Light (RLRL) therapy works to control myopia over 12 months. The main question it aims to answer is: * Can RLRL therapy help slow down the worsening of myopia? Participants will use a red-light therapy investigational device at home, 5 days a week for 12 months.

Eligibility

Age range

6–12 years

Sex

All

Healthy volunteers

No

Interventions

• Device
  Repeated Low-Level Red Light (RLRL) therapy

  RLRL device emits low-level red-light with a wavelength of 650 ± 10 nm. The device provides light at a power of 2.00 ± 0.50 mW.

• Device
  Placebo Device

  Placebo device will match the RLRL in appearance but will not emit light.

Locations (2)